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Summary
Objective: One of the main open questions in chondrocyte transplantation is the fate of the implanted cells in vivo. We intended to establish
prerequisites for such studies in animal models and to show the feasibility of this approach in rabbits. Isolated articular chondrocytes were
retrovirally marked using green ßuorescence protein (GFP) as a cell-speciÞc marker in order to allow an in vivo follow-up of these cells.
Methods: Chondrocytes from rabbits, sheep, cattle and humans were isolated and infected with murine leukemia virus-derived retroviruses
carrying the GFP gene. The inßuence of the host range of three packaging cell lines (PA317, PT67, PG13), start cell concentrations, number
of cell passages and number of infection cycles on the efficiency of infection was investigated. Stability of GFP expression was followed by
FACS analysis, confocal imaging and ßuorescence microscopy. For in vivo follow-up of GFP expression we used marked allogeneic
chondrocyte populations grown on scaffold material and implanted them into full-thickness defects in knee joints of rabbits.
Results: Retroviruses from all three packaging cell lines were able to infect rabbit and human chondrocytes, whereas only retroviruses
released from PG13 cells were able to infect sheep and bovine chondrocytes efficiently. Optimization of the infection with these viruses
resulted in efficiencies of 6090% GFP-expressing chondrocytes. Populations of 100% marked chondrocytes were obtained by cell sorting.
GFP expression stability of such marked chondrocyte populations was followed in monolayer culture and in 3-D culture on different scaffold
materials. The expression of GFP was stable on all tested materials for at least 4 weeks. In monolayer culture GFP expression was stable
for more than 8 months. In vivo, we observed stable GFP expression in the transplants during a four-week time course.
Conclusion: Retroviral GFP gene transfer led to long-term expression in chondrocytes from rabbits, sheep, cattle and humans. Transgene
expression and the number of implanted chondrocytes remain stable for at least 4 weeks in vivo. This method permits a rapid monitoring of
chondrocytes and provides a basis for following the fate of these cells in vivo. © 2002 OsteoArthritis Research Society International
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Cartilage injuries are difficult to treat. Conventional surgical
methods support the healing process, but do not lead to
tissue regeneration of articular cartilage1,2. Transplantation
of allogeneic or autologous cells may enhance treatment of
such defects3,4. For this purpose, chondrocytes are iso-
lated, expanded ex vivo and Þnally implanted. Conßicting
reports on the success of such transplantation raise the
question to which extent the transplanted cells contribute to
the observed wound closure46. While it is generally
accepted that ex vivo monolayer cultivation of chondro-
cytes is accompanied by rapid dedifferentiation several
protocols have been established that allow redifferentiation
of these cells ex vivo79. Furthermore, it remains to be
shown if dedifferentiated cells can redifferentiate in vivo
upon implantation.109To evaluate transplantation of chondrocytes as a thera-
peutic approach it would be important to follow the fate of
implanted chondrocytes inside articular joints. For this
purpose, homogeneously marked populations of chondro-
cytes and long-term expression of the marker gene
are needed in order to distinguish implanted cells from
endogenous ones.
Most commonly used cell-speciÞc markers are
-galactosidase1013 and green ßuorescence protein
(GFP)14. Whereas the Þrst relies on an enzymatic reaction
with substrate addition, GFP can be visualized simply by
blue light excitation which permits vital observation of
GFP-expressing cells. GFP has a half-life time of over 24 h
in mammalian cells15. These characteristics allow a real-
time follow-up during cell culture. Successful in vivo moni-
toring of GFP expression has been already reported in
transgenic animals1619.
Transplantation of genetically modiÞed primary cells like
chondrocytes requires an efficient and stable gene transfer
since such cells can only undergo a certain number of cell
divisions. Gene transfer methods already applied to articu-
lar chondrocytes are transfection20,21 and viral infection
using adenoviruses11,12,22,23, adeno-associated viruses13
and retroviruses10,24. The use of murine retroviruses for
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Fig. 1. Infection efficiency of freshly isolated articular chondro-
cytes. Retroviruses of indicated packaging cells were used for
chondrocyte infection (ndnot determined). PA 317, ; PT 67, ;
PG 13, .Table I
Infection of articular chondrocytes at different passages (P0, P3
and P5). Infection efficiencies are shown in % infected cells of vital
cells (nd—not determined)
Packaging cell line
Receptors
Envelopes
PA317
Pit-2
4070A
PT67
Pit-1, Pit-2
10A1
PG13
Pit-1
GALV
Rabbit chondrocytes
Fresh 18 25 43
P3 19 15 56
P5 19 11 18
Sheep chondrocytes
Fresh 1 0 41
P3 2 1 81
P5 0 0 71
Bovine chondrocytes
Fresh 0 0 25
P3 0 0 91
P5 0 0 86
Human chondrocytes
Fresh 7 nd 5
P3 63 44 69
P5 44 30 64ARTICULAR CHONDROCYTES
Cartilage was obtained from knee joints of mature
female New Zealand white rabbits (Charles River
Germany) and black headed meat sheep (Lower-Saxon
Sheep Utilization), whereas bovine cartilage (6-month-old
calves, Holstein-Friesen, Bahlmann) and human cartilage(two female patients who had undergone reconstructive
surgery, age: 27 years) were acquired from foot joints.
Chondrocytes were cultured in high-glucose Dulbeccos
modiÞed Eagles medium (DMEM) with following additives:
2 mM L-glutamine, 0.1 ml/l non-essential amino acids
(MEM, 100×), 50 mg/l ascorbic acid (tissue-culture grade),
50 mg/l gentamicin, 2.5 mg/l amphotericin B (the Þrst two
passages only) and 10% (v/v) fetal calf serum (FCS).
The enzyme solution for chondrocyte isolation contain-
ing 0.5 mg/ml (0.76 U collagenase activity/ml) collagenase
P (Boehringer Mannheim) and 0.1 mg/ml (3050 U/ml)
hyaluronidase type I-S (Sigma) was freshly prepared in
culture medium with heat-inactivated FCS.
Articular cartilage was harvested aseptically from the
joint surfaces, washed and minced. Chondrocytes were
isolated by enzymatic cartilage digestion under gentle
stirring in an incubator (culture conditions: humidiÞed
atmosphere by 10% [v/v] CO2 at 37°C) overnight. Human
cartilage was additionally treated prior collagenase diges-
tion with 0.05% (w/v) trypsin/ 0.02% (w/v) EDTA containing
phosphate buffered saline (PBS) solution for 30 min under
the same conditions. The obtained chondrocyte suspen-
sion was subsequently Þltered twice through a 100 m and
40 m mesh-diameter nylon cell strainer (Falcon, Becton-
Dickinson). Chondrocyte suspensions were centrifuged at
250 g for 10 min.
Freshly isolated chondrocytes were seeded in culture
ßasks with the following start cell concentrations for rabbits:
4×104 cells/cm2, sheep: 2×104 cells/cm2, cattle: 1×104
cells/cm2, and humans: 8×104 cells/cm2 and cultured
under the previously described conditions. At higher pas-
sages (P1 to P6) two-fold lower cell concentrations were
applied. For long-term cultivation (more than P6) chondro-
cytes of rabbits, sheep, cattle and humans were subpopu-
lated in split ratios of 1:2, 1:4, 1:8 and 1:2, respectively.
Chondrocytes were detached by trypsin/EDTA solution in
an incubator for 15 min and resuspended in culture
medium. For testing the stability of GFP expression after a
freezing/thawing procedure chondrocyte suspensions and
chondrocytes grown on scaffold materials were frozen in
FCS containing 7.5% (v/v) dimethyl sulfoxide at −70°C.gene transduction has become a standard method in gene
therapy approaches. Retroviral gene transfer is efficient
and leads often to long-term transgene expression due to
integration into the host genome. Moreover, virus-speciÞc
immune reactions are not to be expected since no viral
genes are transduced. Up to now, systematic investigations
of retroviral infection of articular chondrocytes have not
been reported. We therefore investigated the efficiency of
retroviral gene transfer into articular chondrocytes of typical
animal models. Rabbits were chosen for allogeneic trans-
plantation experiments4,25. Sheep allow autologous
chondrocyte transplantation into cartilage defects in knee
joints26. Cattle were chosen due to their easy accessibility.
Human chondrocytes were chosen for obvious medical
applications.
Successful retroviral infection depends on the expres-
sion of cellular surface receptors that interact with the viral
envelope proteins. We chose three different packaging cell
lines, which differ in their envelope proteins, and hence in
host range since species-dependent infection patterns
were reported27 and receptor distribution in chondrocytes
is unknown. Retroviruses released from the PA317 cell line
carrying 4070A envelope proteins are capable of infecting
cells via the Pit-2 receptor whereas retroviruses from the
PG13 cell line containing gibbon ape leukemia virus
(GALV) envelope proteins infect cells via the Pit-1 receptor.
Viruses from PT67 cells carry 10A1 envelope proteins and
use both, the Pit-1 and the Pit-2 receptor for infection27,28.
In the present study, stability of GFP expression was
monitored in monolayer culture, in 3-D culture applying
different scaffold materials and in rabbits as an allogeneic
chondrocyte transplantation model.
Osteoarthritis and Cartilage Vol. 10, No. 2 111Isolation of chondrocytes grown on scaffold materials as
well as from the transplants were performed by enzymatic
digestion using 4 mg/ml collagenase and 0.1 mg/ml
hyaluronidase for about 2 h under gentle stirring and cul-
ture conditions.CELL LINES
The murine leukemia virus-based retroviral vector carry-
ing the gene encoding for enhanced GFP (MFG-GFP)29
was stably introduced into the murine packaging cell lines
PT67 (Clontech), PG13 (American Type Culture Collection,
ATCC, CRL-10686) and PA317 (ATCC CRL-9078) by cal-
cium phosphate co-transfection with a plasmid encoding
SV40 promoter driving the neomycin resistance gene
(neoR) followed by a selection for neomycin resistance with
1 mg/ml G418.
The virus titer for PT67 and PA317 cells was determined
on NIH/3T3 (ATCC CRL-1658) cells by FACS analysis to
be 0.6×105 and 6×105 infected cells/ml, respectively. For
PG13 cells a titer of 1.4×105 infected cells/ml was
determined on 293 cells (ATCC CRL-1573).
Sorted GFP-expressing chondrocytes were free of
replication-competent retroviruses (RCRs) (data not
shown). The RCR test was performed according to Spitzer
et al. with slight modiÞcations using 293 cells carrying a
neoR-GFP transducing retroviral vector30. Mobilization of
the retroviral vector was determined by infection of 293
cells, selection for G418 resistance and analysis for GFP
expression by FACS. NIH/3T3 cells producing amphotropic
wild type viruses served as a positive control30.
The 293 cells, packaging cells and NIH/3T3 cells were
maintained in DMEM containing 10% FCS, 2 mM
L-glutamine, 10 U/ml penicillin and 100 g/ml streptomycin
under culture conditions by 5% CO2. The cells were sub-
cultured every 3 days and detached using the trypsin/EDTA
solution.VIRAL INFECTION
All retroviral infections were performed using cell-free
virus-containing supernatant (1×105 infectious viruses)
adjusted to 2 ml of culture medium per well of a 6-well
plate. Fresh medium was added to the packaging cells 24 h
before the virus supernatant was harvested and subse-quently Þltered through a 0.45-m pore-size syringe Þlter
(Sartorius). Chondrocytes were seeded depending on
species and passage. One day prior infection, NIH/3T3
control cells were seeded at a start cell concentration of 104
cells/cm2. All infections were performed in the presence of
8 g/ml Polybrene (Sigma) unless mentioned differently.
1214 h post-infection, virus-containing supernatants were
removed and cells were incubated for further 3 days in
culture medium and eventually analysed by FACS.FLOW CYTOMETRY
Preparations for FACS analysis or cell sorting were
performed according to Spitzer et al. (1999)30. Marked
chondrocytes were analysed with a FACSCalibur or
sorted with a FACSVantage ßow cytometer (both Becton
Dickinson). Data acquisition and analysis were performed
using CellQuest 3.3 (Becton Dickinson).0
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Fig. 2. Analysis of GFP expression stability of GFP-marked and sorted chondrocytes. (A) A population of sorted sheep chondrocytes was
cultivated in monolayer for the indicated passages (P)P5, P12 and P21. (B) Sheep chondrocytes grown for 8 weeks on PLLA scaffold
material were isolated by collagenase/hyaluronidase treatment and analysed for GFP expression.DETERMINATION OF THE DIFFERENTIATION STATUS BY
QUANTITATIVE RT-PCR
The determination of the differentiation status was per-
formed by quantifying the mRNA of collagen type II
(marker of differentiated chondrocytes) and collagen type I
(marker of dedifferentiated chondrocytes) in marked and
unmarked chondrocytes. Collagen type I and II speciÞc
primer sequences were selected with VectorNTI (InforMax)
using sequences (AF 129287 a sheep collagen type I alpha
1 precursor mRNA and X02420 a bovine mRNA
3′-fragment for type II collagen pro-alpha 1 chain) from the
Entrez Nucleotides database (National Center for Biotech-
nology Information, U.S.A.) and ordered by MWG Biotech.
The RNA of chondrocytes was extracted by Trizol rea-
gent (Gibco BRL). All obtained RNA samples were treated
with DNase I (Promega) for 30 min by 37°C for removing
possible contamination with genomic DNA. Reverse tran-
scription was performed at 42°C for 60 min with avian
myeloblastosis virus (AMV) reverse transciptase (Pharma-
cia) using the 3′-primer. QuantiÞcation of cDNAwas accom-
plished by applying the Lightcycler system of Roche. Used
primers and annealing temperatures were as follow: colla-
gen type I, 64°C, 3′-primer: 5′-GGC CAG TGT CTC CTT
TGG GTC CC-3′, 5′-primer: 5′-ATG ACC GAG ACG TGT
112 F. Hirschmann et al.: Retroviral GFP marking of chondrocytesGGA AAC C-3′ and for collagen type II: 60°C, 3′-primer:
5′-GCT GTT CTT GCAGTG GTAGG-3′, 5′-primer: 5′-CAG
CTA TGG AGA TGA CAA CC-3′.SCAFFOLD MATERIALS
The following scaffold materials were chosen for three-
dimensional chondrocyte culture: lyophilized duramater of
brain (Lyodura, B.Braun-Dexon, Spangenberg; thickness:
1 mm) as a biological material and two different types of
synthetic bioresorbable materials consisting of non-woven
meshes of poly(L-lactide) Þbers (PLLA, V19-1, Institute of
Textile Research, Denkendorf, F.R.G.; thickness: 2 mm)
and poly(glycolide-L-lactide) copolymer Þbers (PGA/PLLA,
ratio 9 to 1) glued by a poly-p-dioxanone (PDS) melt
(PGA/PLLA-PDS, Ethisorb 210, Ethicon, Norderstedt,
F.R.G.; thickness: 2 mm)3134. Scaffold materials were
punched into discs measuring 3 mm in diameter. Thesediscs were wetted prior inoculation for about 2 hours in
culture medium. Duramater leafs were separated after
pre-wetting using the inner surface for cell seeding. Each
disc was inoculated with 3×105 cells using 96-well plates
and tissue-culture inserts (Anopore, Nunc).Fig. 3. Images of chondrocytes grown for one week on different scaffold materials. (A) and (B) are 3-D confocal microscope images of sheep
chondrocytes (magniÞcation: 100×). (A) The image shows attached cells on PLLA Þbers. (B) Chondrocytes grew on duramater in monolayer.
(C) and (D) are pictures of human chondrocytes monitored by conventional ßuorescence microscopy (magniÞcation: 12.5×). (C) Human
chondrocytes grown on PGA/PLLA-PDS scaffold material. (D) Homogeneous cell distribution on PLLA scaffold material.CELL IMAGING
Marked chondrocytes were monitored applying conven-
tional ßuorescence microscopy and confocal laser
scanning microscopy (CLSM). The stability of GFP
expression of chondrocytes grown on scaffolds was
followed by ßuorescence microscopy (excitation with
488 nm, Axiovert 135 TV, Carl Zeiss Jena) combined with a
charge-coupled device (CCD) camera (Photometrics)
and an imaging program IPLab Spectrum P 3.1a (Signal
Analytics).
Osteoarthritis and Cartilage Vol. 10, No. 2 113Three-dimensional images were recorded with the LSM
510 confocal laser scanning system from Carl Zeiss Jena.
GFP images were recorded after excitation with the
488-nm line from an argon ion laser (Ion Laser Tech-
nology). Optical sections through scaffolds were recorded
at 0.5 m intervals. Extended focus images were calcu-
lated with Þve sections, and superimposed on a differential
interference contrast image of the cells.ResultsSELECTION OF THE RETROVIRUS TYPE FOR GENE TRANSFER
INTO ARTICULAR CHONDROCYTES OF DIFFERENT SPECIES
Retroviral mediated GFP gene transfer could be demon-
strated in freshly isolated articular chondrocytes from the
four investigated species: rabbit, sheep, cattle and human.
However, remarkable differences were observed.
Retroviruses from all three packaging cell lines were
able to infect freshly isolated rabbit chondrocytes with an
efficiency of 18% (PA317; S.D.: 4, N=6), 25% (PT67; S.D.: 8,
N=6) and 43% (PG13; S.D.: 16, N=6) (Fig. 1 and Table I). In
contrast, only retroviruses of the PG13 cell line were able to
infect freshly isolated sheep and bovine chondrocytes
effectively, with infection efficiencies of 41% (S.D.: 3.5, N=2)
and 25%, respectively (Fig. 1 and Table I). Freshly isolated
human chondrocytes from patients were infected with an
efficiency of 5% using retroviruses from PG13 and 7%
using retroviruses released from PA317 cells (Fig. 1 and
Table I). Infection of murine retroviruses requires prolifer-
ation of cells. Freshly isolated chondrocytes show a very
low proliferation rate, however proliferation is initiated by
culturing.Cell number expansion allowed infection of human
chondrocytes with all different retroviruses at passage 3
(Table I). This experiment showed that retroviruses
released from PT67 cells are capable of infecting human
chondrocytes with a high efficiency of 44%. PG13 released
retroviruses infected human chondrocytes at the same
passage even with 69% (S.D.: 1, N=2) efficiency.
Since retroviruses released by the PG13 packaging cells
infect articular chondrocytes from the different species
most efficiently they were selected for further optimization
studies (Table I).0
140
C
on
ce
n
tr
at
io
n
 o
f 
co
ll
ag
en
 in
 %
0
20
40
60
80
0.4%
100
120
Set
100%
5
93%
0.7%
9
Set
100%
2.1%
7 marked
99.8%
>0%
Number of passages
Fig. 4. Determination of the differentiation status of marked and
unmarked sheep chondrocytes. Collagen type I (h) mRNA were
used as a dedifferentiation marker, whereas collagen type II (")
mRNA was quantiÞed as a marker of differentiated chondrocytes.
Levels of collagen type II in passage 0 (freshly isolated chondro-
cytes) and collagen type I in passage 9 were set as 100%. Marked
chondrocytes are shown in the 7-Marked sample. These cells
were infected in passage 0, sorted in passage 2 and cultured for
further 7 passages. Untreated chondrocytes in passage 9 are a
parallel culture of 7 Marked and hence they are to compare.OPTIMIZATION OF ARTICULAR CHONDROCYTE INFECTION
To determine the optimal infection procedure the inßu-
ence of start cell concentrations (SCCs), passage number,
Polybrene concentration and number of infection cycles
was analysed with retroviruses from PG13 cells.
The optimal start cell concentration (SCC) was shown to
be species-dependent. Freshly isolated rabbit chondro-
cytes showed an infection efficiency of 43% at an SCC of
2×104 cells/cm2. Increasing this cell concentration reduces
the efficiency, e.g. a duplication of the cell concentration led
to an efficiency of 26%. A decrease of the SCC from 2×104
to 1×104 cells/cm2 did not increase efficiency (20%).
Freshly isolated sheep chondrocytes showed infection effi-
ciencies of 60%, 41% and 14% at SCCs of 0.5, 1 and
2×104 cells/cm2, respectively. However, long adaptation
times and reduced growth rates at the SCC of 0.5×104
cells/cm2 favor an SCC of 1×104 cells/cm2. Bovine
chondrocytes showed very high infection efficiencies at low
SCCs (91%, 84% and 60% at SCCs of 0.3, 5 and 1×104
cells/cm2, respectively) at passage 3 (P3). Human
chondrocytes showed a peak of 69% infection efficiency at
an SCC of 4×104 cells/cm2 at passage 3 (P3). InfectionIN VIVO STUDIES
Female New Zealand white rabbits (34 kg in weight,
Charles River Germany) were used for in vivo experiments.
The animals were housed and anaesthetized according to
the German animal guidelines.
All surgical procedures were performed under general
anesthesia initiated with an intramuscular injection of keta-
mine (Ketamin Gra¨ub, Albrecht) and midazolam hydrochlo-
ride (Dormicum, Roche) and supplemented by inhalational
anesthesia with isoßurane (Isoßuran, Lilly). Each rabbit
received a subcutaneous injection of antibiotics (Tardomyo-
cel, BayerVital) and analgesics (Temgesic, Essex Pharma)
prior to the procedure. Through a medial parapatellar
approach 3 mm diameter full-thickness defects were cre-
ated in the medial and lateral condyle as well as in the
patellar surface of the femur of each knee. Rabbits were
allowed free cage activity after the surgical procedure.
Food and water were provided ad libitum.
A total of six rabbits (12 knees) was subdivided into three
groups (1, 2 and 4 weeks). Right knees were used for
transplantation of marked chondrocytes, left knees for
untransduced chondrocytes. Prior transplantation chondro-
cyte populations were grown on 3 mm discs of PLLA
scaffold material for 4 weeks. Animals were killed using the
same procedure as for initiating anesthesia followed by an
intracardiac injection of sodium pentobarbital (Eutha 77,
Essex Pharma). The knee joints were opened and implan-
tation sites were observed by ßuorescence microscopy.
Tissues in these areas were surgically obtained, cells
enzymatically isolated and subsequently counted.
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showed a reduction to 51% and 62%, respectively.
The optimized SCCs for infection of freshly isolated
chondrocytes were: rabbits: 2×104 cells/cm2, sheep:
1×104 cells/cm2, cattle: 0.5×104 cells/cm2 and humans:
8×104 cells/cm2.
The optimal SCCs were shown to be passage-
dependent. This was expected since the chondrocytes
showed higher proliferation rates at higher passage num-
bers. As mentioned before, we found that a further reduc-
tion of the SCC for chondrocytes at higher passage
numbers increased infection efficiency. For example,
freshly isolated sheep chondrocytes (passage 0P0)
showed an infection efficiency of 41% at an SCC of 1×104
cells/cm2, 81% in P3 and 71% in P5 at an SCC of 0.5×104
cells/cm2. During culture in the mentioned passages, cells
began to adapt a Þbroblast-like morphology and the pro-
liferation rate had increased. These results were reßected
by decreased doubling times. Freshly isolated sheep
chondrocytes showed a doubling time of about 3 days after
a four-day adaptation phase without any cell growth,
whereas they show a doubling time of about 2 days at P3
and P5.
Additional infection cycles were investigated for improv-
ing the infection efficiency. Sheep chondrocytes showed
only a slight increase in infection efficiency from 24% by
single infection to 35% by double infection in P2, whereas
rabbit chondrocytes in P2 did not show higher infection
efficiencies by two infection cycles. Thus, we did not use
double infection for further applications.
Different Polybrene concentrations were investigated.
Polybrene is a polycation that neutralizes negative charges
present on virus particles and cells and enhances the viral
titer. However, the optimal Polybrene concentration has to
be determined since it has negative effects on cell stability
in high concentrations. Rabbit chondrocytes showed simi-
lar infection efficiencies using 4 and 8 g/ml Polybrene.
Sheep chondrocytes showed an infection efficiency of 41%
in the presence of 8 g/ml Polybrene and a slight increase
to 47% in the presence of 4 g/ml Polybrene whereas
infection efficiency dropped to 26% in the presence of
2 g/ml Polybrene. Bovine chondrocytes showed an infec-
tion efficiency of 53% in the presence of 2 g/ml Polybrene.
Increasing the concentration to 4 g/ml Polybrene no
remarkable increase in infection efficiency (54%) was
observed whereas in the presence of 8 g/ml Polybrene an
infection efficiency of 82% was achieved. Human chondro-
cytes showed no strong difference in infection efficiency in
the presence of 4 g/ml Polybrene (41%) and in the pres-
ence of 8 g/ml Polybrene (47%). From these data we
conclude that the concentration can be reduced for some
species without a reduction of infection efficiency.
In summary, we determined the optimal retroviral infec-
tion efficiency of articular chondrocytes from four species
using a single infection cycle with PG13 released retrovi-
ruses together with optimized species- and passage-
dependent start cell concentration and with a possiblereduction of Polybrene concentration for some species
from 8 to 4 g/ml. The highest infection efficiencies were
gained in passage 3 (Table I).Fig. 5. Allogeneic chondrocyte transplantation in full-thickness defects in knee joints of rabbits. (A) Marked rabbit chondrocytes grown on
PLLA scaffold Þbers for 4 weeks in vitro. This color picture was taken before transplanting them into osteochondral defects (magniÞcation:
50×). (B), (C) and (D) show femurs obtained after 4 weeks post-transplantation. (B) and (C) are black-and-white photographs whereas (D)
is a color one. (B) The right femur contains implants of marked chondrocytes in both lateral and medial condyles. The same locations in the
left femur contain implants of non-transduced chondrocytes. (C) Marked chondrocytes implanted in the patellar surface of the right femur. In
the left femur, non-transduced chondrocytes were implanted. (D) Implants of marked chondrocytes can be clearly distinguished from the
autoßuorescence of endogenous cartilage. The picture shows a medial condyle 4 weeks after transplantation (magniÞcation: 12.5×). The
implants are bright green. The perspective of the photographs are marked by arrows in the small picture of the same femur.GFP EXPRESSION STABILITY OF MARKED ARTICULAR
CHONDROCYTES IN VITRO
The optimized infection procedure was used to achieve
high numbers of infected chondrocytes. Infected cells were
free of replication-competent retroviruses (see Materials
and methods for details). These infected cells were sub-
jected to cell sorting for obtaining populations in which all
cells express GFP (Fig. 2).
These populations of sorted GFP-marked chondrocytes
were expanded and expression stability was followed in
culture.
In monolayer culture GFP expression was stable in all
investigated species. As an example Fig. 2(A) shows a
population of sorted sheep chondrocytes that demonstrate
very little loss of GFP expression for more than 8 months
(38 passages) in culture ßasks. Moreover, GFP expression
remains stable after thawing and re-culturing. This was
conÞrmed for the same population frozen for one year. Data
from other species showed similar results (not shown).
We next asked if GFP expression is maintained upon
cultivation of marked chondrocytes in 3-D culture on differ-
ent scaffold materials (duramater, PLLA and PGA/PLLA-
PDS) as it is required for transplantation.
Marked chondrocytes of different species efficiently
populate the used scaffold materials [Figs 2(B), 3(A),(D)
and 5(A)]. Attachment of marked chondrocytes on polymer
Þbers and growth of them on duramater were monitored by
confocal laser scanning microscopy [Fig. 3(A),(B)]. Cell
distribution of marked chondrocytes grown on Þber meshes
of synthetic scaffold materials was analysed by ßuor-
escence microscopy [Fig. 3(C),(D)]. GFP-expression of
marked chondrocytes remained stable on all applied mate-
rials during a four-week culture period [Figs 3(A)(D) and
5(A)]. Marked sheep chondrocytes grown on PLLA scaf-
folds conÞrmed stable GFP expression even after an
8-week culture period. After this period, chondrocytes were
isolated by collagenase/hyaluronidase treatment and GFP
expression was determined by FACS analysis [Fig. 2(B)].
More than 98% of cells were marked and no loss of GFP
expression could be detected. Freezing of marked
chondrocytes grown for 4 weeks on PLLA scaffolds and
re-culturing conÞrmed even the expression stability on
scaffolds after a freezing/thawing procedure.
The inßuence of the marking procedure on matrix pro-
duction of chondrocytes was investigated by quantitative
RT-PCR (Fig. 4). For this purpose, freshly isolated sheep
chondrocytes and both marked and untreated chondro-
cytes isolated after 49 passages were compared. The
level of collagen type II mRNAwas determined as a speciÞc
marker for differentiated chondrocytes and collagen type I
mRNA for monitoring dedifferentiation. As expected, cells
116 F. Hirschmann et al.: Retroviral GFP marking of chondrocyteswere rapidly dedifferentiated upon monolayer culture and
collagen type II mRNA nearly disappeared at passage 5
(Fig. 4). However, this was independent of the marking
procedure since we could not observe any differences
between marked cell populations and the non-marked
control populations (Fig. 4: compare passage 9 and 7
Marked).
Histological methods were performed according to
Rudert et al. (2000) using the following stainings:
hematoxylin-eosin for cell distribution, azan for collagens,
alcian blue (pH 1.0) for glycosaminoglycans and safranin-O
for proteoglycans35. Again, although the morphology of
cells conÞrmed dedifferentiation, no difference could be
observed between a marked and a non-marked sheep
chondrocyte population grown for 4 weeks on different
scaffold materials in terms of matrix production (proteo-
glycans, glycosaminoglycans and collagens) and cell
distribution (data not shown).GFP EXPRESSION STABILITY OF MARKED ARTICULAR
CHONDROCYTES IN VIVO
GFP-expression was followed in vivo over a 4-week time
course taking samples after 7, 14 and 28 days. Populations
of marked and non-marked allogeneic chondrocytes grown
on PLLA scaffold material were implanted into three differ-
ent defect sites (medial and lateral condyles, patellar sur-
face of the femur) in knee joints of rabbits. Figure 5(A)
shows such a marked population grown on PLLA prior
transplantation. In all three implantation sites stable GFP
expression could be observed during the whole period. As
an example implants after 4 weeks in vivo are presented in
Fig. 5(B)(D). Figure 5(B) shows the transplantation sites
of both lateral and medial condyles whereas Fig. 5(C)
shows the transplantation site of the patellar surface of
the femur. Moreover, the bright green ßuorescence of
implanted GFP-marked chondrocytes can be clearly distin-
guished from the autoßuorescence of endogenous carti-
lage even after 4 weeks post-transplantation. Figure 5(D)
indicates this for an implant in the medial condyle after
4 weeks in vivo.
Furthermore, the number of marked cells in the implan-
tation sites was nearly stable. We found an average of 90%
(S.D. 12%) of the implanted cells in the defect sites. An
outgrowth of marked cells in endogenous cartilage was not
observed.
Thus, GFP expression of marked chondrocytes remains
stable for at least 4 weeks in vivo. Moreover, the total
number of marked cells in the defect areas was only
minimally decreased.Discussion
Efficient GFP gene transfer and stable long-term GFP
expression in articular chondrocytes of four different
species: rabbits, sheep, cattle and humans could be dem-
onstrated. We achieved marked chondrocyte populations
containing only GFP-expressing cells by cell sorting and
were able to show stable GFP expression in monolayer, in
3-D culture, and in rabbits as an allogeneic chondrocyte
transplantation model.
In previous approaches marked chondrocyte popula-
tions were obtained by transferring a vector carrying the
LacZ gene in combination with the neoR gene into articular
chondrocytes10,11. The LacZ gene encodes for-galactosidase, the neoR gene for resistance against
G418. In these approaches, G418 selection was used for
obtaining populations, which only contain marked cells.
However, selection for drug resistance is time consuming.
Moreover, the neoR gene was shown to have a negative
inßuence on nearby promoters and hence on expression of
other vector sequences e.g. LacZ 3638. Artelt et al.
reported a Þve- to ten-fold expression decrease36. Addition-
ally, LacZ cannot be used to monitor living cells during
cultivation procedure.
Infection studies with three different producer cell lines
showed that retroviruses released from PG13 cells infect
chondrocytes of all four different species most efficiently
(Fig. 1 and Table I). These retroviruses contain GALV
envelope proteins and use the Pit-1 receptor for cell entry.
An optimization of the infection method resulted in species-
and passage-dependent optimized start cell concen-
trations. These species-speciÞc optimized infection proce-
dures were used for obtaining homogeneously GFP-
expressing chondrocyte populations [Fig. 2(A),(B)]. All
these populations did not release RCRs. This is an import-
ant safety requirement, especially for in vivo experiments.
Homogeneously marked chondrocyte populations are a
prerequisite to follow the fate of these cells in vivo. Long-
term stability of GFP-expression of marked populations
was shown in monolayer culture [Fig. 2(A)] and followed
over 8 months. In 3-D culture, the stability of GFP expres-
sion was conÞrmed after an eight-week culture period [Fig.
2(B)]. This was performed in view of a 4-week in vivo
period. Moreover, stable GFP expression of chondrocytes
grown for 4 weeks on scaffold material after a freezing/
thawing procedure may open possibilities for easier han-
dling prior to transplantation. Although most investigations
were performed with chondrocytes originated from healthy
animals, the high number of marked chondrocytes is prom-
ising for chondrocytes of degenerative joints. Infecting
freshly isolated human chondrocytes from patients could
show this. Although infection efficiency was very low (7%)
at P0, a remarkable increase in efficiency to 69% could be
observed at P3 (Fig. 1 and Table I).
After conÞrming long-term stability of GFP expression
in vitro, allogeneic marked chondrocytes were transplanted
in full-thickness defects in knee joints of rabbits. Four
weeks after transplantation GFP was highly and homoge-
neously expressed throughout the implants [Fig. 5(B)(D)].
Furthermore, the sharp border between GFP-marked cells
of the implant and endogenous cartilage did not reveal any
hint for outgrowth of transplanted chondrocytes into the
donor tissue.
These results are in contrast to previously published
in vivo studies of LacZ-marked chondrocytes. In allogeneic
chondrocyte transplantation into full-thickness articular car-
tilage defects in rabbits, Kang et al. observed a decline of
the number of LacZ-marked cells up to less than 5% after 4
weeks in vivo10. Similar results were reported by Baragi et
al.11. The decline of -galactosidase production might be
caused by immune response against allogeneic cells, poor
survival of the transplanted cells, or inactivation of the
transferred LacZ gene. This impedes the interpretation of
in vivo derived data.
The described method of retroviral GFP marking of
chondrocytes makes in vivo tracking of these cells feasible.
This should allow to determine the fate of transplanted
chondrocytes and to further evaluate the potential of
chondrocyte transplantation for the treatment of cartilage
defects.
Osteoarthritis and Cartilage Vol. 10, No. 2 117An important question is the differentiation status of cells
after transplantation. In monolayer culture cells rapidly
dedifferentiate (Fig. 4). However, there is evidence that
under speciÞc culture conditions dedifferentiation can be
reversed to redifferentiation in vitro79. The presented pro-
tocols for efficient and homogeneous GFP marking are a
prerequisite to follow the differentiation status of trans-
planted cells in vivo. Future investigations will show if
dedifferentiated chondrocytes can redifferentiate in a 3-D
environment in vivo.
The GFP-marked chondrocytes could be followed-up in
real-time during the whole in vitro culture period using
conventional ßuorescence microscopy and confocal laser-
scanning microscopy [Fig. 3(A)(D)]. This can be per-
formed on vital cells avoiding Þxation. Consequently, the
described methods represent a rapid and easy way of
cell localization and distribution as well as growth [Figs
3(A)(D) and 5(A)(D)].
Since the described methods provide tools for efficient
gene transduction and long-term transgene expression in
chondrocytes it offers new opportunities for localizing and
observing cells in an in vivo transplantation model (rabbit or
sheep). Additionally, the expression of transgenes in these
cells especially after long-term culture is an important
prerequisite for potential transplantation of genetically
modiÞed cells that may improve healing.Acknowledgments
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